President Donald Trump on Monday announced more than 600 drugs added to his signature drug coupon platform TrumpRx, increasing the number of drugs found within the program by more than 700%.
For years, Americans have been paying too much for prescription drugs because insurance companies and the pharmacy middlemen they own have found ways to jack up costs.
Instead of passing savings directly to patients, these companies often pocketed pricing discounts for themselves while families were left paying high prices at the pharmacy counter.
TRUMP IS RIGHT TO REBALANCE GLOBAL DRUG PRICES
Enter Trump, who said, “Not so fast.”
Through TrumpRx.gov, the White House created a public database that helps Americans find some of the cheapest prices available for prescription drugs. Instead of forcing patients to rely on confusing insurance company pricing schemes, the program helps direct consumers toward lower-cost options that come directly from the drug manufacturers themselves, cutting out many of the middlemen that used to take a cut while hiding the medications’ true cost from the public. For many, even with private insurance, higher-tier copays can still exceed the out-of-pocket cost for some medications through TrumpRx.
TrumpRx has added competition and much-needed sunlight to a system that operated behind closed doors for years, making it far harder for insurers and pharmacy middlemen to inflate prices without patients realizing it. Adults who struggle with diabetes, heart disease, obesity, and other conditions are grateful.
Also thankful are couples who struggle with infertility.
In vitro fertilization treatments are prohibitively expensive but not covered by insurance. The Trump administration negotiated a nearly 85% discount on a trio of IVF drugs.
Through TrumpRx, more consumers seek IVF treatments than almost any other drug. One IVF treatment, EMD Serono, was cut by more than 80%, from about $1,000 to under $200.
Mark Cuban, one of Trump’s most ardent critics, is on record as praising TrumpRx, stating that the Trump administration has “some great people that are making smart moves.”
When it comes to weight loss, Americans can use TrumpRx to purchase Wegovy for $199, a fraction of the original listing price.
Humira, which treats rheumatoid arthritis, was reduced from $7,000 to $950. That drug lost its patent protection in 2023, but generic equivalents are available on TrumpRx for almost $208 a dose.
Genentech will sell its flu treatment Xofluza for about $50, down from $168.
As for diabetes, officials with Merck and Sanofi recently got on board with TrumpRx. Merck added three medications (Januvia, Janumet, and Janumet XR) and cut costs by 74%.
Trump is lowering drug prices not only by creating a fairer and more open and competitive drug market here at home, but also by unleashing the free market for Rx’s abroad.
The president has stressed that the United States must crack down on foreign nations freeloading on American-manufactured pharmaceuticals.
A combination of government-imposed price controls or strict negotiations keep drug prices in other developed areas of the world — Canada and Europe, among them — artificially low.
This forces pharmaceutical companies to recoup their global research and development, manufacturing, regulatory, and profit needs primarily from higher prices charged in the U.S. market.
In other words, the U.S. subsidizes those nations’ drug costs — but the president is working on winding this down.
Trump finalized an agreement with the United Kingdom to increase the net price of new prescription drugs by 25% to make sure citizens of that nation pay their fair share for cutting-edge medicines.
Now his administration has its sights set on Germany, with U.S. trade representative Jamieson Greer and Health Department chief adviser Chris Klomp pushing the country to pay more for prescription drugs.
As the administration continues negotiating with more and more drugmakers, the White House also continues to ensure more medications are added to TrumpRx.
Johnson & Johnson officials announced late last month that they will sell one of their blood thinner medications as well as four of their diabetes medications on TrumpRx. Drug companies such as AbbVie and Genentech will start selling medications at lower prices through the White House’s TrumpRx website.
Despite the legacy media seldom covering the program, more and more people are learning about the many benefits of TrumpRx. At least 15 million people have visited the website thus far.
Whether by forcing healthcare middlemen to compete at home or pressuring foreign governments to stop freeloading off American innovation abroad, Trump is challenging the broken system that kept prescription drug prices high for years.
The media may not want to admit it, but the results speak for themselves: lower prices, more transparency, and real savings for American families.
AMERICA PAYS TOO MUCH FOR MEDICINE. HERE’S WHO IS DOING SOMETHING ABOUT IT
As more Americans discover the program, it will become harder and harder for the press to ignore its success.
We thank the president for his strong leadership on this critical issue.
Christy Lewis is a nurse licensed through the North Carolina Board of Nursing with 30 years of experience in public and private healthcare, known for compassionate patient advocacy and community engagement. She is the co-founder and host of Civic Sound-Off and works with North Carolina Faith & Freedom Coalition supporting voter education and civic involvement across North Carolina.